+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Gene Panel Market by Product and Geography - Forecast and Analysis 2020-2024 - Product Image

Gene Panel Market by Product and Geography - Forecast and Analysis 2020-2024

  • ID: 4895316
  • Report
  • December 2019
  • Region: Global
  • 149 pages
  • TechNavio

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • ArcherDx Inc.
  • BGI Genomics Co. Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GENEWIZ Inc.
  • MORE
Global Gene Panel Market: About this market
The gene panel market analysis considers sales from small panel testing and large panel testing products. Our study also finds the sales of gene panels in Asia, Europe, North America, and ROW. In 2019, the small panel testing segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the rising need to identify a known gene mutation will play a significant role in the small panel testing segment to maintain its market position. Also, our global gene panel market report looks at factors such as the growing use of gene panels in cancer-targeted therapies, increasing the number of people with genetic disorders, and decreasing the cost of NGS gene panel tests. However, challenges in implementing large NGS gene panels, lack of effective treatment for several genetic mutations, and the growing complexity of gene panel tests may hamper the growth of the gene panel industry over the forecast period.

Global Gene Panel Market: Overview

Growing use of gene panels in cancer-targeted therapies
Pharmaceutical companies are investing heavily in research activities to develop targeted therapies for the treatment of cancer. This is driving the demand for gene panels as they are used in the development of targeted therapies for cancer. Gene panel testing provides a wide range of benefits such as providing the genetic basis of an individual’s response to therapy. NGS-based gene panel tests are becoming popular as the first choice for cancer care as they are cost-effective, provide genomic data in a brief time, and examine only clinically important genes. This is driving the use of gene panels to evaluate effective treatments for cancer, which will lead to the expansion of the global gene panel market at a CAGR of about 18% during the forecast period.

Rising use of direct-to-consumer tests
The global gene panel market is expected to benefit from the increase in the use of direct-to-consumer tests. In this method, commercial laboratories provide genetic testing directly to consumers without the involvement of a healthcare professional or an authorization for payment by a third-party payer. The easy access and the increasingly affordable options associated with direct-to-consumer genomic testing have helped the technique gain significant popularity over the recent years. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of a few major players, the global gene panel market is concentrated. The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading gene panel manufacturers, that include Agilent Technologies Inc., ArcherDx Inc., BGI Genomics Co. Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GENEWIZ Inc., Novogene Corp., Personalis Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.

Also, the gene panel market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • ArcherDx Inc.
  • BGI Genomics Co. Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GENEWIZ Inc.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Value Chain Analysis
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Small panel testing - Market size and forecast 2019-2024
  • Large panel testing - Market size and forecast 2019-2024
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Increasing number of collaborations
  • Rising use of direct-to-consumer tests
  • Use of gene panels to identify potential side effects in patients
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Agilent Technologies Inc.
  • ArcherDx Inc.
  • BGI Genomics Co. Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GENEWIZ Inc.
  • Novogene Corp.
  • Personalis Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits
Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendors: Key product offerings
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: Small panel testing - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Small panel testing - Year-over-year growth 2020-2024 (%)
Exhibit 22: Large panel testing - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Large panel testing - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Impact of drivers and challenges
Exhibit 39: Vendor landscape
Exhibit 40: Landscape disruption
Exhibit 41: Vendors covered
Exhibit 42: Vendor classification
Exhibit 43: Market positioning of vendors
Exhibit 44: Agilent Technologies Inc. - Vendor overview
Exhibit 45: Agilent Technologies Inc. - Business segments
Exhibit 46: Agilent Technologies Inc. - Organizational developments
Exhibit 47: Agilent Technologies Inc. - Geographic focus
Exhibit 48: Agilent Technologies Inc. - Segment focus
Exhibit 49: Agilent Technologies Inc. - Key offerings
Exhibit 50: ArcherDx Inc. - Vendor overview
Exhibit 51: ArcherDx Inc. - Product segments
Exhibit 52: ArcherDx Inc. - Organizational developments
Exhibit 53: ArcherDx Inc. - Key offerings
Exhibit 54: BGI Genomics Co. Ltd. - Vendor overview
Exhibit 55: BGI Genomics Co. Ltd. - Product segments
Exhibit 56: BGI Genomics Co. Ltd. - Organizational developments
Exhibit 57: BGI Genomics Co. Ltd. - Key offerings
Exhibit 58: Eurofins Scientific SE - Vendor overview
Exhibit 59: Eurofins Scientific SE - Business segments
Exhibit 60: Eurofins Scientific SE - Organizational developments
Exhibit 61: Eurofins Scientific SE - Segment focus
Exhibit 62: Eurofins Scientific SE - Key offerings
Exhibit 63: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 64: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 65: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 66: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 67: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 68: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 69: GENEWIZ Inc. - Vendor overview
Exhibit 70: GENEWIZ Inc. - Product segments
Exhibit 71: GENEWIZ Inc. - Organizational developments
Exhibit 72: GENEWIZ Inc. - Key offerings
Exhibit 73: Novogene Corp. - Vendor overview
Exhibit 74: Novogene Corp. - Product segments
Exhibit 75: Novogene Corp. - Organizational developments
Exhibit 76: Novogene Corp. - Key offerings
Exhibit 77: Personalis Inc. - Vendor overview
Exhibit 78: Personalis Inc. - Business segments
Exhibit 79: Personalis Inc. - Organizational developments
Exhibit 80: Personalis Inc. - Key offerings
Exhibit 81: QIAGEN NV - Vendor overview
Exhibit 82: QIAGEN NV - Business segments
Exhibit 83: QIAGEN NV - Organizational developments
Exhibit 84: QIAGEN NV - Geographic focus
Exhibit 85: QIAGEN NV - Key offerings
Exhibit 86: Thermo Fisher Scientific Inc. - Vendor overview
Exhibit 87: Thermo Fisher Scientific Inc. - Business segments
Exhibit 88: Thermo Fisher Scientific Inc. - Organizational developments
Exhibit 89: Thermo Fisher Scientific Inc. - Geographic focus
Exhibit 90: Thermo Fisher Scientific Inc. - Segment focus
Exhibit 91: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 92: Validation techniques employed for market sizing
Exhibit 93: Definition of market positioning of vendors
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • ArcherDx Inc.
  • BGI Genomics Co. Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GENEWIZ Inc.
  • MORE
The following companies as the key players in the global gene panel market: Agilent Technologies Inc., ArcherDx Inc., BGI Genomics Co. Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GENEWIZ Inc., Novogene Corp., Personalis Inc., QIAGEN NV, and Thermo Fisher Scientific Inc.

Commenting on the report, an analyst from research team said: “The latest trend gaining momentum in the market is the rising use of direct-to-consumer tests.”

According to the report, one of the major drivers for this market is the growing use of gene panels in cancer-targeted therapies.

Further, the report states that one of the major factors hindering the growth of this market is the lack of effective treatment for several genetic mutations.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Agilent Technologies Inc.
  • ArcherDx Inc.
  • BGI Genomics Co. Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GENEWIZ Inc.
  • Novogene Corp.
  • Personalis Inc.
  • QIAGEN NV
  • Thermo Fisher Scientific Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll